Bio-Rad Labs (BIO) Misses Q1 EPS by 18c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $270.32 --0%
EPS Growth %: -30.7%
Financial Fact:
Gross profit: 280.23M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.7%
Financial Fact:
Gross profit: 280.23M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $0.42, $0.18 worse than the analyst estimate of $0.60. Revenue for the quarter came in at $471.2 million versus the consensus estimate of $463.9 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- Tech eyes recovery after selloff, Micron to report results - What’s moving markets
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
